1463.05 47.45 (3.35%)

2.4M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

US FDA Approval
Cipla gets US FDA nod for ANDA of Paclitaxel injectable suspension with a market size of $88 bn See details

corporate actions

Cipla Ltd. - CIPLA, 500087 corporate action history

Check all corporate actions such as stock splits, bonuses, dividends, mergers & acquisitions, rights issues & board meeting announcements for Cipla Ltd.